MINI REVIEW
Published on 15 Nov 2022
Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
doi 10.3389/fphar.2022.752314
- 1,652 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Research Topics
- Pharmacogenetics of Antimalarials – Primaquine for the Treatment of Plasmodium vivax and Plasmodium falciparum Malaria
Pharmacogenetics of Antimalarials – Primaquine for the Treatment of Plasmodium vivax and Plasmodium falciparum Malaria
6,706
Total downloads
27k
Total views and downloads
Articles
PERSPECTIVE
Published on 26 Nov 2021
Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
doi 10.3389/fphar.2021.784909
- 2,716 views
- 8 citations
BRIEF RESEARCH REPORT
Published on 23 Jul 2021
CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region
doi 10.3389/fphar.2021.542342
- 2,046 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 Apr 2021
CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
doi 10.3389/fphar.2021.654054
- 2,559 views
- 7 citations
ORIGINAL RESEARCH
Published on 09 Apr 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
doi 10.3389/fgene.2021.645688
- 3,227 views
- 2 citations
REVIEW
Published on 15 Mar 2021
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
doi 10.3389/fphar.2021.638885
- 12,596 views
- 35 citations
Published in
Frontiers in Pharmacology
Pharmacogenetics and Pharmacogenomics
Drug Metabolism and Transport
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 5.5 citescore